BioAge Labs

BIOANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$537.912 M

$11.72 +3.99%

Close of 7 Aug 2026

Revenue

$8.99M

#3193 by revenue

Earnings

-$80.6M

Loss-making

Shares outstanding

45,896,909

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#204Shattuck LabsSTTK$557.5M
#205MapLight TherapeuticsMPLT$551.9M
#206BioAge LabsBIOA$537.9M
#207Relmada TherapeuticsRLMD$518.2M
#208EvommuneEVMN$507.1M

Where these numbers come from

Share counts and financials for BioAge Labs are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.